| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $8.19B | +42.1% |
| Cost of Revenue | $4.01B | +18.6% |
| Gross Profit | $4.18B | +75.5% |
| R&D Expense | $2.08B | +6.4% |
| SG&A Expense | $767.1M | -3.9% |
| Operating Income | $1.32B | +283.7% |
| Interest Expense | $187.3M | +2.3% |
| Pre-tax Income | $3.05B | +440.5% |
| Income Tax | $376.5M |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.64B | +178.3% |
| Accounts Receivable | $2.19B | +112.6% |
| Inventory | $1.39B | +34.8% |
| Current Assets | $6.46B | +107.1% |
| Total Assets | $22.29B | +10.3% |
| Current Liabilities | $3.22B | +58.9% |
| Long-term Debt | $4.47B | +10.0% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.75B | +4.1% |
| Capital Expenditures | $354.1M | +24.4% |
| Investing Cash Flow | $2.10B | +797.6% |
| Financing Cash Flow | -$2.16B | -56.0% |
| Free Cash Flow | $1.40B | -0.0% |
| +3981.4% |
| Net Income | $2.67B | +401.7% |
| EPS (Basic) | $3.10 | +403.9% |
| EPS (Diluted) | $3.07 | +401.0% |
| Total Liabilities |
| $7.98B |
| +17.7% |
| Stockholders' Equity | $14.31B | +6.6% |